Effects of acetylbergenin against D-galactosamine-induced hepatotoxicity in rats

被引:49
作者
Lim, HK
Kim, HS [1 ]
Choi, HS
Oh, S
Jang, CG
Choi, J
Kim, SH
Chang, MJ
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Kyungsung Univ, Coll Pharm, Pusan 608736, South Korea
[3] Kyung Hee Univ, Coll Phys Educ, Seoul 130701, South Korea
关键词
acetylbergenin; hepatoprotective effect; D-galactosamine;
D O I
10.1006/phrs.2000.0730
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hepatoprotective effects of acetylbergenin were examined against D-galactosamine (GalN)-induced liver damage in rats, compared with that of bergenin reported previously. Acetylbergenin was synthesized from acetylation of bergenin, isolated from Mallotus japonicus, to increase lipophilic and physiological activities. Acetylbergenin was administered orally once daily for 7 days and then GalN (400 mg kg(-1), i.p.) was injected at 24 h and 96 h after the final administration of acetylbergenin. Acetylbergenin reduced the elevated serum enzyme activities of alanine/aspartate aminotransferase, sorbitol dehydrogenase and gamma -glutamyltransferase and the formation of hepatic malondialdehyde induced by GalN. Acetylbergenin also significantly restored towards normalization the decreased levels of glutathione and the decreased activities of glutathione S-transferase and glutathione reductase induced by GalN. Therefore, these results suggest that acetylbergenin has hepatoprotective effects against GalN-induced hepatotoxicity by inhibiting lipid peroxidation and maintaining an adequate level of GSH for the detoxification of xenobiotics as underlying hepatoprotective mechanisms. In addition, lipophilic acetylbergenin showed more activity in the hepatoprotection than that of the much less lipophilic bergenin reported previously. (C) 2000 Academic Press.
引用
收藏
页码:471 / 474
页数:4
相关论文
共 30 条
[1]   STUDIES OF THE RELATIONSHIP BETWEEN THE CATALYTIC ACTIVITY AND BINDING OF NON-SUBSTRATE LIGANDS BY THE GLUTATHIONE S-TRANSFERASES [J].
BOYER, TD ;
VESSEY, DA ;
HOLCOMB, C ;
SALEY, N .
BIOCHEMICAL JOURNAL, 1984, 217 (01) :179-185
[2]  
Decker K, 1973, Adv Enzyme Regul, V11, P205, DOI 10.1016/0065-2571(73)90017-4
[3]   GALACTOSAMINE HEPATITIS - KEY ROLE OF THE NUCLEOTIDE DEFICIENCY PERIOD IN THE PATHOGENESIS OF CELL INJURY AND CELL-DEATH [J].
DECKER, K ;
KEPPLER, D .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, 1974, 71 :77-106
[4]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[5]  
ELMOFTY SK, 1975, AM J PATHOL, V79, P579
[6]  
Gerlach U., 1965, METHODS ENZYMATIC AN, P761, DOI [10.1016/B978-0-12-395630-9.50138-9, DOI 10.1016/B978-0-12-395630-9.50138-9]
[7]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130
[8]   STUDIES ON MECHANISM OF GALACTOSAMINE HEPATITIS - ACCUMULATION OF GALACTOSAMINE-1-PHOSPHATE AND ITS INHIBITION OF UDP-GLUCOSE PYROPHOSPHORYLASE [J].
KEPPLER, D ;
DECKER, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 10 (02) :219-+
[9]   EXPERIMENTAL HEPATITIS INDUCED BY D-GALACTOSAMINE [J].
KEPPLER, D ;
LESCH, R ;
REUTTER, W ;
DECKER, K .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1968, 9 (02) :279-&
[10]   TRAPPING OF URIDINE PHOSPHATES BY D-GALACTOSAMINE, D-GLUCOSAMINE, AND 2-DEOXY-D-GALACTOSE - A STUDY ON MECHANISM OF GALACTOSAMINE HEPATITIS [J].
KEPPLER, DOR ;
RUDIGIER, JF ;
BISCHOFF, E ;
DECKER, KFA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1970, 17 (02) :246-+